Penn Medicine at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Penn Medicine brings 2 presentations to ASH 2026 in New Orleans, and exhibits at Booth 130. Its presence centres on how real-world data can shape sickle cell disease trial design, a discussion it opens and helps lead.
| Organization | ASH 2026 Attendance |
|---|---|
Penn Medicine Philadelphia, PA | |
University of Pennsylvania's academic health system; its Abramson Cancer Center provides cancer care across hospitals in Pennsylvania, New Jersey and Delaware. | Booth Exhibiting at Booth 130 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Session Real-World Data Applications in Sickle Cell Disease Trial Design Using sickle cell disease registries and health records to build external control arms, track safety after approval, and define pain as a trial endpoint. |
Instantly find 20 buyers from Penn Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction